-
Agios Innovative Other Structure Activator reaches Phase 3 Clinical End and is expected to file a regulatory application in the second quarter
Time of Update: 2021-03-09
Agios announced in December that mitapivat had also reached its main endpoint in phase 3 clinical trials of ACTATE in adult patients with acetone kinase deficiency who did not require regular blood transfusions.
-
Giffeitini was "named" small molecules targeted drug anti-tumor to "change the day"?
Time of Update: 2021-03-09
Figure 2 Pharmaceutical segment composition in the field of anti-tumor drugs according to the PDB drug comprehensive database statistics (see Figure 3), in the small molecular targeting drug family, we found that imatinib, giffeitinib and ecstasy in 2016, cumulative sales reached 1,155 million yuan, accounting for 61.8% of the entire family at that time!
-
Transcript for 142 pharmaceutical companies sunbathe 2020! Kyusju Tong... Net profit exceeded $3 billion
Time of Update: 2021-03-09
's biopharmace product pipeline is rich, research and development investment is large, currently only Adamo single anti-injection (commodity name: Gree Li) in 2020 listed for sale, the product is still in the market development stage, operating income is in a period of growth, is expected to continue to generate losses in 2020.
-
New use of poison - A's cream, B's honey
Time of Update: 2021-03-09
It wasn't until 1998, when the New England Journal of Medicine reported on studies at memorial Sloan-Kettering Cancer Center and Cornell Medical School that As2O3 was treated for APL patients and was almost completely relieved, that the international medical community widely accepted the therapeutic effects of As2O3 on APL.
-
First! Well-known medical enterprises Bekang Medical is about to go public
Time of Update: 2021-03-09
Public information shows that Beckon Medical's PGT-A kit can screen embryos for normal development before implantation (a chromosomal disease often associated with failed IVF implants), the first and first high-volume gene sequencing kit approved by the State Drug Administration, marking the birth of China's PGT third-generation IVF "certificated" industrial genetic testing market.
-
Nexpovio, the first nuclear output inhibitor, is about to be approved for review by China
Time of Update: 2021-03-09
Selinexor is the world's first oral selective nuclear output inhibitor (SINE), approved in the United States under the name Xpovio, for the treatment of the hematoma field's two major adaptors - multiple myeloma (MM) and diffuse large B-cell lymphoma (DLBCL).
-
The latest news from the national collection came out of the fifth batch of time
Time of Update: 2021-03-09
With the normalization of national harvesting, varieties, time have become traceable, pharmaceutical enterprises should do a good job in advance of market research, adjust their product structure, m
-
After showing good news, pharmaceutical companies will meet their tenth consecutive limit
Time of Update: 2021-03-09
Like Hengrui Pharmaceuticals such an announcement of the market value of the magic, that is the research and development pipeline up, a new drug clinical registration step by step for the camp, are relying on products to fight the world.
-
Good policy has been introduced the whole country will add a number of three-level hospitals
Time of Update: 2021-03-09
, "county and village medical service capacity improvement" received 2,756 million yuan in financial subsidies, county-level hospitals as the leading hospitals become the focus of construction and upgrading objects.
to establish and improve the rural three-level medical and health service network based on county-level hospitals, township hospitals and village health rooms.
-
According to the survey, the growth rate of medical expenses in the country's basic medical insurance coverage rate of 96.8% has slowed
Time of Update: 2021-03-09
Basic health insurance coverage reached 96.8 percent, and the growth rate of medical expenses slowed in terms of health insurance coverage and utilization rate, the report data showed that the coverage rate of basic medical insurance in the survey areas reached 96.8 percent, an increase of 1.7 percentage points over 2013, and the participation rate of basic medical insurance for residents in urban and rural areas was 96.1 percent and 97.6 percent, respectively.
-
Myovant/Pfizer releases clinical data for Relugolix Phase 3, a new drug for endometriosis
Time of Update: 2021-03-09
A combination of relugolix, estradiol and acetaminophen once a day can reduce clinically significant symptoms in endometriosis women within a year, according to the results of the latest Phase III long-term expansion study published by Pfizer and Myovant.
-
Report that a pharmaceutical company has been fined 150,000! Another drug company was fined 420,000 for failing to make the difference in loading
Time of Update: 2021-03-09
Photo One of the pharmaceutical companies was fined because of the report, and the other pharmaceutical company was fined for failing to qualify for the difference in the amount of kidney capsules.
-
The release of the latest documents from the national collection distribution enterprises is equally great
Time of Update: 2021-03-09
the whole country, Shanghai issued a supplementary document On January 20, Shanghai Sunshine Pharmaceutical Purchasing Network released the "National Drug Centralized Purchase Shanghai Regional Supplemental Document (GY-YD2021-1)", which provides detailed requirements for enterprise declaration, drug distribution, quality testing, tri-party agreement, payment of goods, and use of selected drugs in Shanghai.
-
When the fourth batch of 90 standard medicines is reported
Time of Update: 2021-03-09
On December 17th, Hubei Provincial Health Insurance Bureau issued a Notice on the Reporting of Procurement Data on the Scope of The Fourth Batch of National Organizations' Centralized Drug Purchase Varieties, notifying medical institutions at all levels to fill in the procurement demand online, requiring the completion of data reporting as required by 17:00 on December 21, and completing the examination and reporting of medical institutions in their jurisdictions by 17:00 on December 25.
-
State Office issued with volume procurement "20", special procurement included in the national procurement!
Time of Update: 2021-03-09
On January 29th, the General Office of the State Council issued the Opinions on Promoting the Normal institutionalization of drug centralized belt procurement, which made an important deployment for t
-
Gan Li Pharmaceuticals Phase 1 candidate drug was approved by the FDA Fast Track
Time of Update: 2021-03-09
The one-year survival rate of glioblastoma was 39.3%.
the second and fifth years after diagnosis, the survival rate dropped to 16.9 per cent and 5.5 per cent, respectively.
survival time for untreated patients is only three months.
-
Vaccines - a never-out-of-time "golden good"
Time of Update: 2021-03-09
our bodies recognize that the protein should not exist and produce T lymphocytes and B lymphocytes, which remember how to fight the virus that causes COVID-19 if we are infected in the future.
-
The original price of 19,000 fell to 648 such medical supplies began to purchase
Time of Update: 2021-03-09
1, a maximum drop of 95%, began to implement January 10, according to Henan News Broadcasting, the results of the crown stent belt purchase has been officially landed in Henan Province, located in Zhengzhou City, Huazhong Outside Hospital intervention operating room, patients officially use the reduced price of the stent - from the original price of 19,000 yuan to 648 yuan.
-
Analysis: "Change" and Its "Control" under the GMP System
Time of Update: 2021-03-09
It is normal for drugs to change during the production process. Even in developed countries with relatively high drug research and development capabilities, it is very common for a variety to change
-
A pharmaceutical company is punished for not treating drugs that are over-time
Time of Update: 2021-03-09
Party: Guangxi Huatianbao Pharmaceutical Co., Ltd. Illegal Facts: Law enforcement officials of our Bureau from October 27, 2020 to October 28, 2020, in accordance with the law to carry out daily supe
